Close Menu

In the PNAS Early Edition this week, a public-private research collaboration among academicians and investigators at array technology vendors reports its development of a 6.9 million-feature oligonucleotide "human transcriptome array for high-throughput clinical studies." When compared to that of RNA-seq, the team says, this transcriptome array "allows comprehensive examination of gene expression and genome-wide identification of alternative splicing as well as detection of coding S

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.